Amgen and AstraZeneca report positive lung cancer trial results

2 sources ·3 articles ·Sep 9, 05:16 UTC Astrazeneca Amgen

2 outlets - including Investing and Kalkinemedia - are covering this story. Highlights AstraZeneca reports a survival benefit in extensive-stage small cell lung cancer. IMFINZI gains support as part of an advanced treatment combination. The result strengthens AstraZenecas wider oncology strategy. AstraZeneca has re…

Covered by 2 outlets

Investing 2 Kalkinemedia 1

All coverage · 3 articles

Kalkine Media UK ·Sep 9, 05:16 UTC

AstraZeneca (LSE:AZN) Strengthens Lung Cancer Story

Highlights AstraZeneca reports a survival benefit in extensive-stage small cell lung cancer. IMFINZI gains support as part of an advanced treatment combination. The result strengthens AstraZenecas wider oncology strategy. AstraZeneca has re…

Investing.com Canada ·Sep 9, 04:58 UTC